As of 11:38am ET
| 0.0001 / +0.00%|
The 3 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 6.75, with a high estimate of 15.00 and a low estimate of 6.70. The median estimate represents a +23.85% increase from the last price of 5.45.
The current consensus among 3 polled investment analysts is to Hold stock in Juniper Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.